Why intelligent classification of clinical trial data is so important
Blog: OpenText
Only one or two in 10,000 compounds that enter pre-clinical trials will ever make it to approval. That journey will take on average 12 years and cost $2.6 billion or more. Adding these facts together, we’ve reached a situation where increasing pressure on R&D has seen return on investment shrink from over 10% in 2010 …
The post Why intelligent classification of clinical trial data is so important appeared first on OpenText Blogs.
Leave a Comment
You must be logged in to post a comment.